ArticleThe Lancet regional health. Europe2022

Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.

Cees C van den Wijngaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.